Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

[DOPPS estimate of patient life years attributable to modifiable hemodialysis practices in France.]

[DOPPS estimate of patient life years attributable to modifiable hemodialysis practices in France.] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • [DOPPS estimate of patient life years attributable to modifiable hemodialysis practices in France.] Abstract Text:

    In this study, we used a prevalent cross-sectional sample of French hemodialysis patients from Dialysis Outcomes and Practice Patterns Study (DOPPS) 2 (2002-2004) to determine the percentage of patients whose values failed to meet targets in six different areas of hemodialysis practice (dialysis dose, anemia, serum phosphorus (PO(4)), serum calcium (Ca), serum albumin and catheter use for vascular access). Cox survival models, with adjustments for patient characteristics, were used for these analyses to estimate mortality hazard ratios (HR). Based on the mortality HR, the fraction of patients outside each target and the total HD population in France, we estimated the number of patient life years that could potentially be gained if every chronic, in-center hemodialysis patient in France who is currently outside of the specified target was able to achieve it. The proportion of patients failing to meet one of the six practice targets in France varied from 15% (dialysis dose) to 75% (albumin) while the percentage of patients complying with all six targets was restricted to 1.2%. The relative risk of mortality (RR) associated with being outside these targets varied from 1.12 to 1.46. Based on these two measures the life-years survival was estimated. The projected number of patients and life years potentially gained from adherence to the six targets was estimated close to 10,600 years-patient. In conclusion, this study suggests large opportunities to improve hemodialysis patient care in France still exist. Compliance with two major practice targets, such as albumin and restriction of catheter use will save highly significant life years of hemodialysis patient. Implementing and strict adherence to national and international guidelines should serve as a basic inspiration for continual improvement of hemodialysis patient care.

    [DOPPS estimate of patient life years attributable to modifiable hemodialysis practices in France.] Publishing Authors By Initials

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    [DOPPS estimate of patient life years attributable to modifiable hemodialysis practices in France.] Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Néphrologie & thérapeutique

    VOLUME: 4

    Page Numbers: 256-65

    Journal Abbreviation: Nephrol. Ther.

    ISSN: 1769-7255

    DAY: 15

    MONTH: 04

    YEAR: 2008

    [DOPPS estimate of patient life years attributable to modifiable hemodialysis practices in France.] Information

    Number of References:

    LANGUAGE: fre

    NlmUniqueID: 101248950

    [DOPPS estimate of patient life years attributable to modifiable hemodialysis practices in France.] Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: [DOPPS estimate of patient life years attributable to modifiable hemodialysis practices in France.] Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for [DOPPS estimate of patient life years attributable to modifiable hemodialysis practices in France.]

    AFFILIATION: Néphrologie, dialyse et soins intensifs, hôpital Lapeyronie, CHRU de Montpellier, 371, avenue du Doyen-G.-Giraud, 34295 Montpellier cedex 05, France.

    Country: France

    France Research PublicationFrance Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Nephrol Ther

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    DOPPS estimate of patient life years attributable to modifiable hemodialysis practices in France Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News